Bioanalytical method development for monoclonal antibodies: advances and challenges

Publish Year: 1404
نوع سند: مقاله ژورنالی
زبان: English
View: 48

This Paper With 15 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CMBR-5-1_005

تاریخ نمایه سازی: 16 مهر 1403

Abstract:

Monoclonal antibodies (mAbs) represent a cornerstone of modern therapeutic strategies, targeting a wide array of diseases with unprecedented specificity. Developing and validating bioanalytical methods for mAbs are critical to ensuring their efficacy, safety, and regulatory compliance. This review discusses the recent advances in bioanalytical technologies and the persistent challenges faced in the field. Significant progress has been made in chromatographic techniques, mass spectrometry, and capillary electrophoresis, enhancing the analysis of mAbs in terms of resolution, sensitivity, and throughput. Innovations such as high-resolution mass spectrometry and automated capillary electrophoresis systems have transformed the mAb characterization landscape. However, challenges remain, primarily due to the complex nature of mAbs, which necessitates the development of susceptible and specific methods to determine their pharmacokinetic profiles and detect low-abundance impurities accurately. Moreover, the stringent and evolving regulatory requirements demand robust and reproducible analytical methods. This review emphasizes the need for continuous technological innovation and adaptation to address these challenges effectively.

Authors

Sudha Kallam

Department of Pharmaceutical Sciences Vignan's Foundation for Science, Technology & Research (Deemed to be University), Guntur-Tenali Rd, Vadlamudi, Andhra Pradesh-۵۲۲۲۱۳, India

Anoop Bodapati

Department of Pharmaceutical Sciences Vignan's Foundation for Science, Technology & Research (Deemed to be University), Guntur-Tenali Rd, Vadlamudi, Andhra Pradesh-۵۲۲۲۱۳, India

Alapati Reddy

Department of Pharmaceutical Analysis, Nalla Narasimha Reddy Education Society, Group of Institutions, Via Narapally, Ghatkesar Mandal, Korremula Rd, Hyderabad, Telangana ۵۰۰۰۸۸, India

Konatham Reddy

Department of Pharmacy, University College of Technology, Osmania University Main Road, Amberpet, Hyderabad ۵۰۰۰۰۷, India

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ecker DM, Jones SD, Levine HL The therapeutic monoclonal antibody ...
  • Camperi J, Lippold S, Ayalew L, Roper B, Shao S, ...
  • Singh S, Tank NK, Dwiwedi P, Charan J, Kaur R, ...
  • Wang Z, Huang AS, Tang L, Wang J, Wang G ...
  • Grilo AL, Mantalaris A (۲۰۱۹) The increasingly human and profitable ...
  • Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J ...
  • Vázquez‐Rey M, Lang DA (۲۰۱۱) Aggregates in monoclonal antibody manufacturing ...
  • van den Broek I, Niessen WMA, van Dongen WD (۲۰۱۳) ...
  • Keizer RJ, Huitema ADR, Schellens JHM, Beijnen JH (۲۰۱۰) Clinical ...
  • Dirks NL, Meibohm B (۲۰۱۰) Population pharmacokinetics of therapeutic monoclonal ...
  • Oude Munnink T, Henstra M, Segerink L, Movig K, Brummelhuis‐Visser ...
  • Damen CWN, de Groot ER, Heij M, Boss DS, Schellens ...
  • Bender JLG, Adamson PC, Reid JM, Xu L, Baruchel S, ...
  • Hoofnagle AN, Wener MH (۲۰۰۹) The fundamental flaws of immunoassays ...
  • Lee JW, Kelley M, King LE, Yang J, Salimi-Moosavi H, ...
  • Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, ...
  • Onami I, Ayabe M, Murao N, Ishigai M (۲۰۱۴) A ...
  • Willeman T, Jourdil J-F, Gautier-Veyret E, Bonaz B, Stanke-Labesque F ...
  • Fung EN, Bryan P, Kozhich A (۲۰۱۶) Techniques for quantitative ...
  • Háda V, Bagdi A, Bihari Z, Timári SB, Fizil Á, ...
  • Iwamoto N, Shimada T, Umino Y, Aoki C, Aoki Y, ...
  • Iwamoto N, Takanashi M, Hamada A, Shimada T (۲۰۱۶) Validated ...
  • Iwamoto N, Shimada T, Terakado H, Hamada A (۲۰۱۶) Validated ...
  • Iwamoto N, Yonezawa A, Matsubara K, Shimada T (۲۰۱۹) Acceleration ...
  • Mu R, Huang Y, Bouquet J, Yuan J, Kubiak RJ, ...
  • Iwamoto N, Shimomura A, Tamura K, Hamada A, Shimada T ...
  • Iwamoto N, Hamada A, Shimada T (۲۰۱۸) Antibody drug quantitation ...
  • Ishii-Watabe A, Shibata H, Nishimura K, Hosogi J, Aoyama M, ...
  • Fiorotti CK (۲۰۱۸) Immunogenicity considerations for antibody–drug conjugates: A focus ...
  • Iwamoto N, Yokoyama K, Takanashi M, Yonezawa A, Matsubara K, ...
  • Tran JC, Tran D, Hilderbrand A, Andersen N, Huang T, ...
  • Namera A, Saito T (۲۰۱۹) Monolithic Spin Column Extraction in ...
  • Shida H, Naito T, Shibata K, Yamada Y, Kawakami J ...
  • Sankaran PK, Poskute R, Dewis L, Watanabe Y, Wong V, ...
  • El Amrani M, van den Broek MPH, Göbel C, van ...
  • Beck A, Goetsch L, Dumontet C, Corvaïa N (۲۰۱۷) Strategies ...
  • Zahid MJ, Ijaz A, Hidayat W, Jan MA, Rafi H, ...
  • Firth D, Bell L, Squires M, Estdale S, McKee C ...
  • Hallin EI, Serkland TT, Bjanes TK, Skrede S (۲۰۲۴) High-throughput, ...
  • Meng J, Guo Q, Zhai X, Yang S, Wang S, ...
  • Wirth FN, Abu Attieh H, Prasser F (۲۰۲۴) OHDSI-compliance: a ...
  • Chen J, Yin S, Wu Y, Ouyang J (۲۰۱۳) Development ...
  • Schlecht J, Jooss K, Moritz B, Kiessig S, Neususs C ...
  • Raju CM, Elpa DP, Urban PL (۲۰۲۴) Automation and Computerization ...
  • Giammarile F, Knoll P, Kunikowska J, Paez D, Estrada Lobato ...
  • McKertish CM, Kayser V (۲۰۲۳) Current Protein Conjugation Strategies and ...
  • Manousi N, Ntorkou M, Tzanavaras PD, Zacharis CK (۲۰۲۳) A ...
  • Capretti M, Del Bianco G, Giammaria V, Boria S (۲۰۲۴) ...
  • نمایش کامل مراجع